Menduh Oruc

Menduh Oruc

Auto-generated profile, based on publicly available information

Menduh Oruc

Dicle University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2018 in Turkish Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
MOMenduh Oruç
Menduh Oruç
This study aims to investigate the prognostic factors affecting survival and clinical outcomes in patients exposed to pediatric penetrating thoracic injury. A t otal o f 2 67 p ediatric p enetrating t horacic injury patients (217 males, 50 females; mean age 10.8 years; range, 3 to 17 years) who were treated at our hospital during the recent 20 years were analyzed retrospectively. Penetrating thoracic injuries were divided into three groups: incisive/stabbing injuries, gunshot injuries, explosive injuries. Patients" age, gender, New Injury Severity Score, injury type, injuries accompanying thoracic trauma, types of treatment applied, length of hospital stay, and morbidity and mortality outcomes were examined. Their prognostic characteristics were compared to their injury types, New Injury Severity Scores, lengths of hospital stay and complications. Of the patients, 103 were exposed to gunshot injuries, 128 to incisive/stabbing injuries, and 36 to explosive injuries. Of the penetrating thoracic injuries, while 211 (79%) were isolated injuries, 56 (21%) were accompanying non-thoracic injuries. Mean New Injury Severity Score was 13±10. Of the patients, 50 (18.6%) were treated with medical therapy alone, 199 (74.5%) with tube thoracostomy, and 18 (6.7%) with thoracotomy. Fiftyone patients (19%) developed complications. Length of hospital was 9±2.7 days. Twenty-one patients (7.9%) died. New Injury Severity Scores, rates of combined injuries, complications, length of hospital stay, and mortality were higher in explosive injuries (p<0.05). Pediatric penetrating thoracic injuries may be observed in all age groups in children, the most severe type being explosive injuries. Prognostic factors may vary according to injury type, complications, treatment approach, and presence of accompanying non-thoracic injuries.

25 March 2024
Verified
Book Chapter
Closed access
OAOzlem Abakay
Ozlem Abakay
MOMenduh Oruc
Menduh Oruc
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis. Mycobacterium tuberculosis is transmitted by inhalation of droplets. Medication is the main component of TB treatment. When starting tuberculosis treatment, first a case definition is made and the treatment regimen is determined. The treatment regimen consists of two periods: an initial period and a maintenance period. First-generation medications used in TB treatment: Isoniazid (INH), Rifampicin (RIF), pyrazinamide (PZA), ethambutol (EMB) and streptomycin. Secondary medications used in the treatment of resistant TB. Treatment success rate increases with directly observed treatment.

23 October 2026 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
PDF file
MOMenduh Oruç
Menduh Oruç
Bennur EsenBennur Esen
Bennur Esen
AAAhmet Engin Atay
Ahmet Engin Atay
DAMLA YILDIZDAMLA YILDIZ
DAMLA YILDIZ
SOSerdar Onat
Serdar Onat
RÜRefik Ülkü
Refik Ülkü
Background: Pulmonary hydatid cyst disease (PHCD) remains a significant public health problem in endemic regions. Aims: To evaluate the demographic, serological, radiological, and surgical characteristics of patients with PHCD and to identify factors associated with hepatic involvement and postoperative outcomes. Methods: This retrospective study included 515 consecutive patients who underwent surgical treatment for PHCD at Dicle University Faculty of Medicine between 2013 and 2025. Demographic characteristics, cyst features, indirect fluorescent antibody (IFA) test results, concomitant hepatic involvement, surgical procedures, postoperative outcomes, and complications were analyzed. Results: Among 515 patients, 275 (53.4%) were male and 240 (46.6%) were female. Female patients were significantly older than male patients (28.0 ± 18.0 vs. 23.8 ± 18.4 years, p = 0.002). Hepatic involvement was significantly associated with positive IFA test results (p < 0.001), bilateral pulmonary disease (p < 0.001), multiple pulmonary cysts (p < 0.001), female sex (p = 0.045), and left-sided pulmonary involvement (p = 0.019). Blood group distribution was not associated with hepatic involvement (p = 0.773), although IFA positivity differed significantly among ABO blood groups (p = 0.006). Larger cyst size was associated with longer hospital stay (r = 0.130, p = 0.003) and prolonged drainage duration (r = 0.094, p = 0.034). Perforated cysts were associated with increased hospital stay (r = 0.180, p < 0.001) and drainage duration (r = 0.139, p = 0.002). Pediatric patients had significantly larger cysts than adults (p = 0.007). Conclusions: Positive IFA results, multiple pulmonary cysts, and bilateral lung involvement are associated with concomitant hepatic hydatid disease. Cyst size and perforation status significantly influence postoperative recovery, particularly hospital stay and drainage duration. Surgical treatment provides excellent outcomes with low reoperation rates and no disease-related mortality in experienced centers.

25 March 2024
Verified
Book Chapter
Closed access
ASAtalay Sahin
Atalay Sahin
MOMenduh Oruc
Menduh Oruc
Empyema is a serious health problem that can affect individuals of all ages. Although there has been some change in treatment modalities with the advancement of technology, there is still no standard approach to treatment. The most common cause of parapneumonic empyema is parapneumonic or postpneumonic effusions. Inappropriate diagnosis and intervention can result in chronic parapneumonic empyema. This can lead to pleural thickening, which can further reduce lung and thorax volume and impair respiratory function. In more advanced cases, more invasive surgical procedures may be needed, such as thoracotomy and decortication. Alternatively, myoplasty or thoracomyplasty may be employed. As the main principle in empyema treatment is to match the stage, early diagnosis and intervention are crucial. Consequently, the primary objective is to administer appropriate antibiotics, perform appropriate drainage, and, in cases of loculation, implement early debridement (fibrinolytic therapy, VATS) in order to reduce the necessity for thoracotomy.

19 June 2024
Verified
Book Chapter
Closed access
HNHelin Nerede
Helin Nerede
MOMenduh Oruc
Menduh Oruc
Idiopathic pulmonary fibrosis is characterized by an aberrant wound healing response following lung injury, leading to excessive fibroblast proliferation and extracellular matrix deposition. Fibroblasts and myofibroblasts play a central role in the disease process. They proliferate abnormally and produce collagen and other matrix proteins, resulting in fibrosis. Epithelial-mesenchymal transition where epithelial cells transform into mesenchymal cells, contributes to the pool of fibroblasts in the fibrotic lung. Mutations in genes related to telomere maintenance (TERT, TERC) and surfactant proteins (SFTPC, SFTPA2) have been linked to familial and sporadic idiopathic pulmonary fibrosis cases. Environmental triggers as exposure to environmental factors such as cigarette smoke, occupational dusts, and viral infections may trigger or exacerbate the disease in genetically predisposed individuals. The hallmark pattern seen in IPF is Usual Interstitial Pneumonia (UIP) that includes patchy fibrosis that occurs in a heterogeneous, patchy distribution within the lung. Honeycombing characterized by formation of cystic spaces lined by bronchiolar epithelium, typically found in subpleural and paraseptal regions. Fibroblastic foci comprised of clusters of proliferating fibroblasts and myofibroblasts at the leading edge of fibrotic areas. Temporal and spatial heterogeneity with the presence of normal lung, early (fibroblastic foci) and late (honeycombing) lesions within the same lung biopsy, indicating ongoing disease activity.